| C01EB09 |
C01EB09 ubidecarenone |
| C01EB10 |
C01EB10 adenosine |
| C01EB11 |
C01EB11 tiracizine |
| C01EB13 |
C01EB13 acadesine |
| C01EB15 |
C01EB15 trimetazidine |
| C01EB16 |
C01EB16 Ibuprofen |
| C01EB17 |
C01EB17 ivabradine |
| C01EB18 |
C01EB18 ranolazine |
| C01EB21 |
C01EB21 regadenoson |
| C01EB22 |
C01EB22 meldonium |
| C01EB23 |
C01EB23 tiazotic acid |
| C01EX |
C01EX Other cardiac combination products |
| C02 |
C02 Antihypertensives |
| C02A |
C02A Antiadrenergic agents, centrally acting |
| C02AA |
C02AA Rauwolfia alkaloids |
| C02AA01 |
C02AA01 rescinnamine |
| C02AA02 |
C02AA02 reserpine |
| C02AA03 |
C02AA03 combinations of rauwolfia alkaloids |
| C02AA04 |
C02AA04 rauwolfia alkaloids, whole root |
| C02AA05 |
C02AA05 deserpidine |
| C02AA06 |
C02AA06 methoserpidine |
| C02AA07 |
C02AA07 bietaserpine |
| C02AA52 |
C02AA52 reserpine, combinations |
| C02AA53 |
C02AA53 combinations of rauwolfia alkoloids, combinations |
| C02AA57 |
C02AA57 bietaserpine, combinations |
| C02AB |
C02AB Methyldopa |
| C02AB01 |
C02AB01 methyldopa (levorotatory) |
| C02AB02 |
C02AB02 methyldopa (racemic) |
| C02AC |
C02AC Imidazoline receptor agonists |
| C02AC01 |
C02AC01 clonidine |